Informing decision makers seeking to improve vaccination programs: case-study Serbia.

Autor: Sauboin C; Health Economics Department, GSK, Wavre, Belgium.; Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands., Mihajlović J; Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.; Mihajlović Health Analytics (Miha), Novi Sad, Serbia., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands., Geets R; Health Economics Department, GSK, Wavre, Belgium., Antic D; Pharma Research & Development, GSK, Beograd, Serbia., Standaert B; Health Economics Department, GSK, Wavre, Belgium.

Publikováno v: Journal of market access & health policy [J Mark Access Health Policy] 2021 Jul 25; Vol. 9 (1), pp. 1938894. Date of Electronic Publication: 2021 Jul 25 (Print Publication: 2021).

Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs.

Autor: Standaert B; HEBO bv, Antwerpen, Belgium. baudouin.standaert@skynet.be., Sauboin C; The University Medical Center Groningen, Groningen, The Netherlands.; Boehringer Ingelheim, Global Market Access Excellence, Ingelheim am Rhein, Germany., Leclerc QJ; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Connolly MP; Unit of Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands.

Publikováno v: PharmacoEconomics [Pharmacoeconomics] 2021 Feb; Vol. 39 (2), pp. 257-269. Date of Electronic Publication: 2020 Nov 25.

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.

Autor: Standaert B; Health Economics, GSK, Wavre, Belgium., Sauboin C; Value Evidence, GSK, Wavre, Belgium., DeAntonio R; R&D Health Outcomes Latin America, GSK, Panama City, Panama., Marijam A; Value Evidence and Outcome, GSK, Collegeville, PA, USA., Gomez J; R&D Health Outcomes, GSK, Buenos Aires, Argentina., Varghese L; Regional Health Outcomes, GSK, Singapore, Singapore., Zhang S; Regional Health Outcomes, GSK, Singapore, Singapore.

Publikováno v: Journal of market access & health policy [J Mark Access Health Policy] 2020 Jan 31; Vol. 8 (1), pp. 1719588. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).

AnophelesModel: An R package to interface mosquito bionomics, human exposure and intervention effects with models of malaria intervention impact.

Autor: Golumbeanu, Monica^1,2 (AUTHOR) monica.golumbeanu@swisstph.ch, Briët, Olivier^1,2 (AUTHOR), Champagne, Clara^1,2 (AUTHOR), Lemant, Jeanne^1,2 (AUTHOR), Winkel, Munir^1,2 (AUTHOR), Zogo, Barnabas³ (AUTHOR), Gerhards, Maximilian^1,2 (AUTHOR), Sinka, Marianne⁴ (AUTHOR), Chitnis, Nakul^1,2 (AUTHOR), Penny, Melissa^1,2,5,6 (AUTHOR), Pothin, Emilie^1,2 (AUTHOR), Smith, Tom^1,2 (AUTHOR)

Publikováno v: PLoS Computational Biology. 9/13/2024, Vol. 20 Issue 9, p1-14. 14p.

Mathematical Analysis of Malaria Epidemic: Asymptotic Stability With Cost‐Effectiveness Study.

Autor: Nana-Kyere, Sacrifice¹ (AUTHOR) nana.sacrifice@vvu.edu.gh, Seidu, Baba¹ (AUTHOR), Nantomah, Kwara¹ (AUTHOR), Adel, Waleed¹ (AUTHOR) waleedadel@mans.edu.eg

Publikováno v: Journal of Applied Mathematics. 7/15/2024, Vol. 2024, p1-44. 44p.